Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
TFX · NYSE · United States · Surgical & Medical Instruments & Apparatus
In shortTELEFLEX INC is loss-making, generates cash and carries moderate debt, with revenue growing (+17.2% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 5.9% | 36/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -45.4% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -24.5% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 1.6% | 11/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.54× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.85× | 64/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 7.64× | 0/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.18× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.56 | 63/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 0.1% | 20/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 5 | 80/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 21.7% | 31/100 |
| Operating margin volatility | 7.3% | 43/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -10.6% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 2,810 | 2,791 | 1,712 | 1,700 | 1,993 |
| Cost of revenue | 1,260 | 1,260 | 672 | 662 | 872 |
| Gross profit | 1,550 | 1,531 | 1,040 | 1,037 | 1,121 |
| Research & development | 131 | 154 | 114 | 109 | 145 |
| Selling, general & admin | 860 | 864 | 623 | 675 | 720 |
| Operating income | 628 | 500 | 259 | 104 | 118 |
| Interest expense | 57 | 54 | 85 | 84 | 100 |
| Pre-tax income | 559 | 446 | 185 | 26 | 25 |
| Income tax | 74 | 83 | 42 | (31) | (34) |
| Net income | 485 | 363 | 356 | 70 | (906) |
| Diluted EPS | $10.23 | $7.68 | $7.53 | $1.48 | −$20.25 |
| Diluted shares (millions) | 47 | 47 | 47 | 47 | 45 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
3.56 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026